S.J. Harland - Concepedia

Author

S.J. Harland

Also Known As

M H Cullen, S Harland, S J Harland, S. Harland, S. J. HARLAND, S. J. Harland, S.J Harland, S.J. HARLAND, S.J. Harland, StephenJ Harland

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

University College London Royal Marsden Hospital North Middlesex Hospital Royal Marsden NHS Foundation Trust Institute of Cancer Research

About

S.J. Harland is an author at University College London specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.5K
2	Health Sciences	2	2	183
3	Natural Sciences	2	2	290
4	Education	1	1	16
5	Engineering	1	1	151

S.J. Harland

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II A. Hilary Calvert, S.J. Harland, David R. Newell, Cancer Chemotherapy and Pharmacology OncologyMedicineClinical StudiesPharmacotherapyCancer Treatment	1982	485
Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer Anne O’Donnell, Ian Judson, Mitch Dowsett, British Journal of Cancer	2004	383
Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. M.H. Cullen, Sally Stenning, M C Parkinson, Journal of Clinical Oncology	1996	318
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function. S.J. Harland, David R. Newell, Zahid H. Siddik, PubMed Cis-diammine-1,1-cyclobutane Dicarboxylate PlatinumPharmacotherapyFree PlatinumUnchanged CbdcaPharmacokinetics	1984	247
2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial M. Bachner, Yohann Loriot, Marine Gross‐Goupil, Annals of Oncology Positron Emission TomographyEngineeringMedical ImagingSempet TrialPet-mri	2011	151
Phase I studies with carboplatin at the Royal Marsden Hospital A. Hilary Calvert, S.J. Harland, David R. Newell, Cancer Treatment Reviews OncologyRadiation OncologyMedicineRoyal Marsden Hospital	1985	133
Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001) Steve Nicholson, Emma Hall, S.J. Harland, British Journal of Cancer	2013	132
Non-Hodgkin's lymphoma of the testis A. Crellin, B. Vaughan Hudson, M.H. Bennett, Radiotherapy and Oncology Lymphoid NeoplasiaHistopathologyDiagnosisPathologyLymphatic Disease	1993	114
A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma A. Horwich, R.T.D. Oliver, P M Wilkinson, British Journal of Cancer	2000	108
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. A. Horwich, David P. Dearnaley, J. Nicholls, Journal of Clinical Oncology Surgical OncologyCancer ManagementBleomycin Combination ChemotherapyCeb ChemotherapyGynecology	1991	101

Page 1